S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:CDLX

Cardlytics (CDLX) SEC Filings & 10K Form

$13.16
-0.12 (-0.90%)
(As of 04:25 PM ET)
Compare
Today's Range
$12.16
▼
$13.60
50-Day Range
$8.57
▼
$19.17
52-Week Range
$2.57
▼
$19.57
Volume
1.07 million shs
Average Volume
1.27 million shs
Market Capitalization
$496.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Recent Cardlytics SEC Filings

Export to Excel
DateFilerForm TypeView
09/19/2023
3:30 PM		Cardlytics (Subject)
CAS Investment Partners, LLC (Filed by)
Form SC 13D/A
09/08/2023
5:16 PM		Cardlytics (Subject)
Temsamani Karim Saad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
2:24 PM		Cardlytics (Subject)
Temsamani Karim Saad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:12 PM		Cardlytics (Issuer)
Hill Scott A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:05 PM		Cardlytics (Issuer)
Temsamani Karim Saad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
1:20 PM		Cardlytics (Subject)
Lynton Nicholas Hollmeyer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
2:48 PM		Cardlytics (Subject)
Lynton Nicholas Hollmeyer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2023
3:30 PM		Cardlytics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2023
2:23 PM		Cardlytics (Subject)
Christiansen Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2023
7:04 AM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
7:05 AM		Cardlytics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/10/2023
6:01 AM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:19 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4/A
07/05/2023
6:48 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
5:39 PM		Cardlytics (Issuer)
Temsamani Karim Saad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
4:48 PM		Cardlytics (Subject)
Temsamani Karim Saad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
4:48 PM		Cardlytics (Subject)
Lynton Nicholas Hollmeyer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
5:31 PM		Cardlytics (Issuer)
Christiansen Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:20 PM		Cardlytics (Subject)
CAS Investment Partners, LLC (Filed by)
Form SC 13D
06/23/2023
2:14 PM		Cardlytics (Subject)
Christiansen Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/25/2023
5:28 PM		Cardlytics (Issuer)
Lapic S Aimee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
4:01 PM		BALEN JOHN V (Reporting)
Cardlytics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
4:02 PM		Adams David Leslie (Reporting)
Cardlytics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
3:05 PM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
3:31 PM		Cardlytics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
8:31 PM		Cardlytics (Issuer)
Christiansen Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
6:30 AM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
11:15 PM		Cardlytics (Filer)
Form EFFECT
04/12/2023
4:29 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2023
4:30 PM		Cardlytics (Issuer)
Temsamani Karim Saad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2023
3:19 PM		Cardlytics (Filer)
Form DEFA14A
04/10/2023
3:08 PM		Cardlytics (Filer)
Form ARS
04/04/2023
6:36 AM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2023
3:36 PM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2023
10:44 AM		Cardlytics (Subject)
CAS Investment Partners, LLC (Filed by)
Form SC 13G/A
01/23/2023
3:40 PM		Cardlytics (Issuer)
Gupta Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2023
3:22 PM		Cardlytics (Issuer)
Gupta Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2023
3:13 PM		Cardlytics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/23/2023
3:16 PM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2023
3:08 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2023
3:09 PM		Cardlytics (Issuer)
Christiansen Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2022
4:30 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2022
4:31 PM		Cardlytics (Issuer)
Christiansen Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2022
12:50 PM		Cardlytics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/10/2022
4:01 PM		Cardlytics (Issuer)
Laube Lynne Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2022
4:03 PM		Cardlytics (Issuer)
Grimes Scott D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
3:48 PM		Cardlytics (Issuer)
Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
3:49 PM		Cardlytics (Issuer)
Cardlytics (Issuer)
Laube Lynne Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
3:10 PM		Cardlytics (Issuer)
Lynton Nicholas Hollmeyer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
3:47 PM		Cardlytics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2022
3:08 PM		Cardlytics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:CDLX) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -